--- title: "Natco Pharma’s cancer-drug sales in India will fall 20% by March 2027." description: "India has approved a 30% cap on trade margins for around 110 cancer drugs outside existing price controls, including 35 patented medicines. The cap limits hospital markups but not manufacturer prices," url: "https://bilby.ai/predictions/p/161/natco-pharma-s-cancer-drug-sales-in-india-will-fall-20-by-march-2027" markdown: "https://bilby.ai/predictions/p/161/natco-pharma-s-cancer-drug-sales-in-india-will-fall-20-by-march-2027.md" index: "https://bilby.ai/llms.txt" --- > For agents: Bilby answers questions about what governments do, from documents collected at source and checked by research analysts. To ask Bilby yourself, connect to its MCP server at https://pulse.bilby.ai/mcp (setup: https://docs.bilby.ai/developers/mcp-server). Every page on this site is also markdown: add .md to its address, or send Accept: text/markdown. https://bilby.ai/llms.txt lists them all. # Natco Pharma’s cancer-drug sales in India will fall 20% by March 2027. - **Made:** 12 Oct 2026 - **By:** Owen Bae - **Market:** India - **Outcome:** Unresolved India has approved a 30% cap on trade margins for around 110 cancer drugs outside existing price controls, including 35 patented medicines. The cap limits hospital markups but not manufacturer prices, so domestic drugmakers are most affected because branded generics have thus far relied on hospital markups averaging 170% to drive sales. Natco faces the greatest risk as India’s largest domestic oncology generics maker. When Dehli imposed a similar cap on 42 drugs back in March 2019, Natco’s domestic sales fell 37% within five months. Natco is therefore likely to lose oncology market share to competing brands already priced inside the cap. [Ask Bilby about this prediction](https://pulse.bilby.ai/?prompt=Natco%20Pharma%E2%80%99s%20cancer-drug%20sales%20in%20India%20will%20fall%2020%25%20by%20March%202027.) ## Ask Bilby about it Carry the prediction into a question: what has changed since, who decides, and who is exposed. - [What has changed since it was made?](https://pulse.bilby.ai/?prompt=What%20has%20changed%20since%20Bilby%20predicted%20this%3F%20Natco%20Pharma%E2%80%99s%20cancer-drug%20sales%20in%20India%20will%20fall%2020%25%20by%20March%202027.) - [Who decides whether it happens?](https://pulse.bilby.ai/?prompt=Who%20decides%20whether%20this%20happens%3F%20Natco%20Pharma%E2%80%99s%20cancer-drug%20sales%20in%20India%20will%20fall%2020%25%20by%20March%202027.) - [Who gains and who loses if it does?](https://pulse.bilby.ai/?prompt=Who%20gains%20and%20who%20loses%20if%20this%20happens%3F%20Natco%20Pharma%E2%80%99s%20cancer-drug%20sales%20in%20India%20will%20fall%2020%25%20by%20March%202027.) ## More from India 18 predictions on India so far, newest first. - 29 Oct 2026 · [Reliance Industries’ diesel export margins will come under pressure in 2027, putting roughly US$6 billion in annual gross profit at risk.](https://bilby.ai/predictions/p/195/reliance-industries-diesel-export-margins-will-come-under-pressure-in-2027-putti) · Unresolved - 15 Oct 2026 · [India will avoid new US tariffs under the Graham Act when President Trump makes his decision on 18 October.](https://bilby.ai/predictions/p/167/india-will-avoid-new-us-tariffs-under-the-graham-act-when-president-trump-makes-) · True - 14 Oct 2026 · [India’s state-owned power producer NTPC will fail to secure binding green ammonia or methanol export contracts by the end of 2027, forgoing US$120 million a year in export premiums.](https://bilby.ai/predictions/p/163/india-s-state-owned-power-producer-ntpc-will-fail-to-secure-binding-green-ammoni) · Unresolved [All 18 from India](https://bilby.ai/predictions/log?tag=india) · Marked true or false when each resolves ## See what we’re seeing next. New predictions in the Asia Daily Take, free every weekday, and in Bilby whenever you have a question. [Get the Asia Daily Take](https://bilby.ai/asia#asia-daily-take) · [Try Bilby](https://pulse.bilby.ai/sign-up)